MicroRNA Exert Macro Effects on Cancer Bone Metastasis Scott R. BaierYihong Wan Osteoporosis and Cancer (M Nanes and M Drake, Section Editors) 27 July 2016 Pages: 163 - 169
The Role of the Microenvironment in Prostate Cancer-Associated Bone Disease Christina J. TurnerClaire M. Edwards Osteoporosis and Cancer (M Nanes and M Drake, Section Editors) 26 August 2016 Pages: 170 - 177
Fibrous Dysplasia/McCune-Albright Syndrome: Clinical and Translational Perspectives Cemre RobinsonMichael T. CollinsAlison M. Boyce Epidemiology and Pathophysiology (J Cauley and B Dawson-Hughes, Section Editors) 04 August 2016 Pages: 178 - 186
Cortical Bone Porosity: What Is It, Why Is It Important, and How Can We Detect It? D. M. L. CooperC. E. KawalilakJ. D. Johnston Biomechanics (M Silva and K Jepsen, Section Editors) 13 September 2016 Pages: 187 - 198
Risk Factors, Epidemiology and Treatment Strategies for Metabolic Bone Disease in Patients with Neurological Disease S. BinksR. Dobson Secondary Causes of Osteoporosis (S Warden, Section Editor) 15 August 2016 Pages: 199 - 210
Do Selective Serotonin Reuptake Inhibitors (SSRIs) Cause Fractures? Stuart J. WardenRobyn K. Fuchs Secondary Causes of Osteoporosis (SJ Warden, Section Editor) 05 August 2016 Pages: 211 - 218
Osteonecrosis of the Jaw—a Bone Site-Specific Effect of Bisphosphonates Jenny A. F. VermeerGreetje A. P. RendersVincent Everts Craniofacial Skeleton (WE Roberts, Section Editor) 29 July 2016 Pages: 219 - 225
Advances in Controlled Drug Delivery for Treatment of Osteoporosis T. A. Asafo-AdjeiA. J. ChenD. A. Puleo Regenerative Biology and Medicine in Osteoporosis (T Webster, Section Editor) 09 August 2016 Pages: 226 - 238
Nanotechnology Treatment Options for Osteoporosis and Its Corresponding Consequences Donglei WeiJinsuh JungLei Yang Regenerative Biology and Medicine in Osteoporosis (T Webster, Section Editor) 19 August 2016 Pages: 239 - 247